SynBioBeta Speaker

Michele Stansfield

Co-founder & CEO

Cauldron Ferm

YEAR

25

May 2025, SynBioBeta

Speaker

Michele is the co-founder and CEO of Cauldron. She was the driving force behind Cauldron’s management acquisition of Agritechnology, a bioscience company based in regional Australia that developed the proprietary hyper-fermentation technology at Cauldron’s core. Having served as Agritechnology’s General Manager for over a decade, using microbes to produce vaccines, food, feed and fuel, Michele has industry-leading expertise in the scale-up and commercialization of continuous fermentation biomanufacturing. With a background in biomedical science and cellular and molecular biology, Michele started her career with Pfizer focused on a novel pharmaceutical therapy used in the pork industry. Michele holds a BSc (Honours) in Biomedical Science, Cellular and Molecular Biology from the University of Western Sydney.‍

SynBioBeta 2025 - Keynote

Continuous Fermentation – How Close Is It to Commercial Reality?

Continuous fermentation has significant potential to lower the cost of biomanufacturing, but how close to commercial reality is the technology? A group of industry experts will dig into the state of technology development and potential paths to implementation.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Conference Content

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Conference Content

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

VIP Pass

9,995

USD

Conference Pass +

VIP Dinner

VIP Reception

Concierge Intros

Conference Content

Purchase Pass

Purchase Pass

Free cancelation through 2 weeks before the event, if you book before October 31st.

Previous Speakers Include

Sign Up
Sign Up